SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-040635
Filing Date
2013-07-18
Accepted
2013-07-18 18:11:40
Documents
1
Period of Report
2013-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 - SOLOWAY rrd386007.html 4  
1 FORM 4 - SOLOWAY rrd386007.xml 4 3797
  Complete submission text file 0001181431-13-040635.txt   5321
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSCEPT PHARMACEUTICALS INC 1003 W CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address
Soloway Thomas P (Reporting) CIK: 0001454280 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51967 | Film No.: 13975599